13 active not recruiting. 13 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 13 | Active not recruiting 13 |
| Phase 2 | 5 | Active not recruiting 5 |
Follow Malignant Solid Neoplasm: new trials by email Literature Review of Malignant Solid Neoplasm trials Research Report on Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers Computed Tomography, Fludeoxyglucose F-18, Gallium Ga 68 FAPi-46 - Anal Carcinoma, Bladder Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2025-08-01 | 2026-10-20 |
| Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors Atezolizumab, Biospecimen Collection, Computed Tomography - Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 86 | 2022-11-17 | 2026-07-14 |
| Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers Computed Tomography, Gallium Ga 68 FAPi-46, Positron Emission Tomography - Bladder Carcinoma, Cervical Carcinoma | Phase 1 | Active not recruiting | Jonsson Comprehensive Cancer Center | 26 | 2020-08-27 | 2026-02-05 |
| Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia Best Practice, Mesenchymal Stem Cell - COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 65 | 2020-07-29 | 2026-10-05 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Infliximab, Vedolizumab - Colitis, Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 47 | 2020-07-09 | 2026-07-15 |
| Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol Biospecimen Collection, Carboplatin, Iohexol - Malignant Solid Neoplasm | Phase 1 | Active not recruiting | NRG Oncology | 350 | 2020-01-15 | 2026-08-07 |
| Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery Eribulin Mesylate, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Liposarcoma, Malignant Abdominal Neoplasm | Phase 1 | Active not recruiting | OHSU Knight Cancer Institute | 15 | 2018-03-19 | 2026-04-08 |
| 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients Computed Tomography, Fluorine F 18-fluoroazomycin Arabinoside, Positron Emission Tomography - Malignant Breast Neoplasm, Malignant Colorectal Neoplasm | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 25 | 2017-09-22 | 2026-10-08 |
| Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies Avelumab, Ivuxolimab, Radiation Therapy - Advanced Malignant Solid Neoplasm, Castration-Resistant Prostate Carcinoma | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 173 | 2017-08-02 | 2026-10-23 |
| Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 11 | 2017-05-08 | 2026-10-21 |
| Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer Biopsy Procedure, Blood Sample, Bone Scan - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 57 | 2016-02-12 | 2026-09-15 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Bladder Small Cell Neuroendocrine Carcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 152 | 2015-07-22 | 2026-10-15 |
| Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | Phase 1 / Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 75 | 2014-03-24 | 2026-08-11 |
Brain Neoplasms (3) · Hematologic Neoplasms (3) · Urinary Bladder Neoplasms (3) · Adrenal Gland Neoplasms (2) · Breast Neoplasms (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Transitional Cell (2) · Cholangiocarcinoma (2) · Melanoma (2) · Neuroendocrine Tumors (2) · Pancreatic Neoplasms (2) · Penile Neoplasms (2) · Prostatic Neoplasms (2) · Sarcoma (2) · Testicular Neoplasms (2)
Neoplasms (11) · Neoplasms by Site (9) · Neoplasms by Histologic Type (7) · Male Urogenital Diseases (5) · Neoplasms, Germ Cell and Embryonal (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Urogenital Diseases (5) · Digestive System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Neoplasms, Nerve Tissue (4)
Magnetic Resonance Spectroscopy (7) · Specimen Handling (4) · Biopsy (3) · Fluorodeoxyglucose F18 (3) · CTLA-4 Antigen (2) · FAPI-46 (2) · Ipilimumab (2) · Nivolumab (2) · Blood Specimen Collection (1) · CT-P13 (1) · Carboplatin (1) · Disulfides (1) · Immunoglobulin G (1) · Infliximab (1) · Iohexol (1)
National Cancer Institute (NCI) (5) · M.D. Anderson Cancer Center (4) · Jonsson Comprehensive Cancer Center (2) · NRG Oncology (1) · OHSU Knight Cancer Institute (1)
United States (13) · Australia (1) · Canada (1) · Puerto Rico (1)
Jeremie Calais (2) · Amanda Olson (1) · Andrea B Apolo (1) · Aung Naing (1) · Franklin C Wong (1) · Lara E Davis (1) · Mary F Wedekind Malone (1) · Pranshu Mohindra (1) · Roisin M Connolly (1) · Ryan J Sullivan (1) · Sarah E Taylor (1) · Yinghong Wang (1)
PMID 32827353, PMID 32915679, PMID 35031545, PMID 38954785, PMID 40139261, PMID 40721981, PMID 41646361, PMID 42501677
UM1CA186691 (2), UM1CA186716 (2), UM1CA186717 (2), U01CA062490 (1), U01CA132194 (1), U10CA180868 (1), UM1CA186686 (1), UM1CA186688 (1), UM1CA186689 (1), UM1CA186690 (1), UM1CA186709 (1), UM1CA186712 (1), UM1CA228823 (1), ZIABC011078 (1)